Shunji Endo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shunji Endo has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
Masaharu Higashida
15 shared publicationsTomio Ueno
12 shared publicationsYoshinori Fujiwara
Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
10 shared publicationsToshimasa Okada
9 shared publicationsHisako Kubota
Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
7 shared publicationsKazuhiko Yoshimatsu
7 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (6) , 1349-1359
A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
Background: There is currently no established chemotherapy regimen for early recurrence of pathological stage III gastric cancer (GC) following adjuvant chemotherapy with docetaxel plus S-1 (DS) after D2 gastrectomy. We aimed to evaluate the efficacy and safety of ramucirumab plus irinotecan in patients with GC who experienced early recurrence during or within 6 months after DS adjuvant chemotherapy. Methods: This prospective, open-label, multicenter phase II trial enrolled eligible patients treated at 25 centers of the Osaka Gastrointestinal Cancer Chemotherapy Study Group in Japan. Patients received ramucirumab (8 mg/kg) and irinotecan (150 mg/m 2 ) every 2 weeks. The primary endpoint was overall survival (OS), and secondary endpoints included progression-free survival (PFS), objective response rate (ORR), and safety. The sample size was set at 40 based on a threshold median OS of 7 months and an expected median OS of 11 months, with a one-sided alpha error of 0.05 and a power of 0.80. Results: Between November 2019 and July 2023, 43 patients were enrolled, and 39 were included in the analysis after excluding three ineligible patients and one who did not initiate protocol treatment. The median OS was 15.9 months (95% CI: 8.8–42.0; p = 0.003). The median PFS was 5.5 months (95% CI: 3.9–8.1), and the ORR was 38.5%. Grade ≥ 3 adverse events, including neutropenia (25.6%) and hypertension (25.6%), were observed in more than 20% of patients. Conclusion: Ramucirumab plus irinotecan demonstrated promising efficacy and manageable toxicity in patients with early recurrence of GC following adjuvant DS therapy. Trial registration: This study was prospectively registered in the Japan Registry of Clinical Trials (jRCTs05119071, October 6, 2019, https://jrct.niph.go.jp/latest-detail/jRCTs051190071 ).
- 16 September 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (6) , 1349-1359
Open AccessA multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
Background: There is currently no established chemotherapy regimen for early recurrence of pathological stage III gastric cancer (GC) following adjuvant chemotherapy with docetaxel plus S-1 (DS) after D2 gastrectomy. We aimed to evaluate the efficacy and safety of ramucirumab plus irinotecan in patients with GC who experienced early recurrence during or within 6 months after DS adjuvant chemotherapy. Methods: This prospective, open-label, multicenter phase II trial enrolled eligible patients treated at 25 centers of the Osaka Gastrointestinal Cancer Chemotherapy Study Group in Japan. Patients received ramucirumab (8 mg/kg) and irinotecan (150 mg/m 2 ) every 2 weeks. The primary endpoint was overall survival (OS), and secondary endpoints included progression-free survival (PFS), objective response rate (ORR), and safety. The sample size was set at 40 based on a threshold median OS of 7 months and an expected median OS of 11 months, with a one-sided alpha error of 0.05 and a power of 0.80. Results: Between November 2019 and July 2023, 43 patients were enrolled, and 39 were included in the analysis after excluding three ineligible patients and one who did not initiate protocol treatment. The median OS was 15.9 months (95% CI: 8.8–42.0; p = 0.003). The median PFS was 5.5 months (95% CI: 3.9–8.1), and the ORR was 38.5%. Grade ≥ 3 adverse events, including neutropenia (25.6%) and hypertension (25.6%), were observed in more than 20% of patients. Conclusion: Ramucirumab plus irinotecan demonstrated promising efficacy and manageable toxicity in patients with early recurrence of GC following adjuvant DS therapy. Trial registration: This study was prospectively registered in the Japan Registry of Clinical Trials (jRCTs05119071, October 6, 2019, https://jrct.niph.go.jp/latest-detail/jRCTs051190071 ).
- 20 May 2026
- Published by S. Karger AG in Digestive Surgery
- p. 1-19
Prognostic Significance of Nutritional and Inflammatory Factors in Gastric Cancer Surgery
Introduction: Various nutritional and inflammatory biomarkers have been proposed to predict prognosis in cancer patients. This study aimed to identify the most significant of these, along with clinical features, in gastric cancer patients who underwent gastrectomy. Methods: We retrospectively analyzed gastric cancer patients who underwent gastrectomy. Preoperative markers included mGPS(Modified Glasgow Prognostic Score), NLR(Neutrophil-to-Lymphocyte Ratio), CAR(CRP to Albumin ratio), PNI( Prognostic Nutritional Index), and CONUT (Controlling Nutrition Status)score. Postoperative markers were CRPmax, postoperative complications, and operative procedures. The primary endpoints were overall survival (OS) and recurrence-free survival (RFS). Survival was analyzed with the Kaplan–Meier method. Key prognostic factors were identified using stepwise univariate and multivariable Cox regression. Results: 360 patients were analyzed. Stepwise Cox analysis showed mGPS as the strongest preoperative predictor of OS and RFS. When including both pre- and postoperative variables, age, pathological stage, and surgical procedure were independent prognostic factors. In a model limited to modifiable factors, mGPS and postoperative complications independently predicted both OS and RFS, while surgical procedure independently predicted RFS only. Conclusions: Improving preoperative mGPS and minimizing postoperative complications may enhance survival after gastrectomy. When appropriate, stomach-preserving procedures (e.g., subtotal distal gastrectomy) should be favored over total gastrectomy.
- 20 May 2026
- Published by S. Karger AG in Digestive Surgery
- p. 1-19
Prognostic Significance of Nutritional and Inflammatory Factors in Gastric Cancer Surgery
Introduction: Various nutritional and inflammatory biomarkers have been proposed to predict prognosis in cancer patients. This study aimed to identify the most significant of these, along with clinical features, in gastric cancer patients who underwent gastrectomy. Methods: We retrospectively analyzed gastric cancer patients who underwent gastrectomy. Preoperative markers included mGPS(Modified Glasgow Prognostic Score), NLR(Neutrophil-to-Lymphocyte Ratio), CAR(CRP to Albumin ratio), PNI( Prognostic Nutritional Index), and CONUT (Controlling Nutrition Status)score. Postoperative markers were CRPmax, postoperative complications, and operative procedures. The primary endpoints were overall survival (OS) and recurrence-free survival (RFS). Survival was analyzed with the Kaplan–Meier method. Key prognostic factors were identified using stepwise univariate and multivariable Cox regression. Results: 360 patients were analyzed. Stepwise Cox analysis showed mGPS as the strongest preoperative predictor of OS and RFS. When including both pre- and postoperative variables, age, pathological stage, and surgical procedure were independent prognostic factors. In a model limited to modifiable factors, mGPS and postoperative complications independently predicted both OS and RFS, while surgical procedure independently predicted RFS only. Conclusions: Improving preoperative mGPS and minimizing postoperative complications may enhance survival after gastrectomy. When appropriate, stomach-preserving procedures (e.g., subtotal distal gastrectomy) should be favored over total gastrectomy.
- 21 January 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (2) , 387-397
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902)
Background Large type 3 (≥ 8 cm) and type 4 gastric cancers are associated with extremely poor prognoses. The phase III JCOG0501 trial, which evaluated neoadjuvant S-1 plus cisplatin, failed to demonstrate any survival benefits. Docetaxel, oxaliplatin, and S-1 (DOS) have been explored as more effective perioperative regimens for these tumors. Methods Eligible patients had large type 3 or type 4 gastric cancer without distant metastases, except for positive peritoneal cytology (CY). Patients received three cycles of neoadjuvant DOS (docetaxel 40 mg/m2, oxaliplatin 100 mg/m2, and oral S-1 at 80 mg/m2/day for 14 days), followed by gastrectomy with ≥ D2 lymphadenectomy and one year of adjuvant docetaxel plus S-1. The primary endpoint was the 3 year progression-free survival (PFS) rate, with an expected value of 60% and a threshold of 45%. A one-sample log-rank test was performed with an α level of 0.10. Results Of the 48 patients enrolled, 27 had type 4 tumors (56.2%), and 10 (20.8%) had CY1. Overall, 91.7% of patients completed neoadjuvant DOS. R0 resection rate was achieved in 89.6% of patients, a pathological response grade ≥ 1b in 66.7%, and negative CY conversion in 80.0%. The 3-year PFS rate was 37.5% (95% confidence interval [CI], 24.1–50.6%; 80% CI 28.6–46.4%; p = 0.960), and the 3-year overall survival rate was 52.1% (95% CI 37.2–65.0%). Conclusions Although neoadjuvant DOS therapy demonstrated favorable pathological responses, the 3-year PFS did not exceed the predefined threshold, and a survival benefit was not demonstrated.
- 21 January 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (2) , 387-397
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902)
Background Large type 3 (≥ 8 cm) and type 4 gastric cancers are associated with extremely poor prognoses. The phase III JCOG0501 trial, which evaluated neoadjuvant S-1 plus cisplatin, failed to demonstrate any survival benefits. Docetaxel, oxaliplatin, and S-1 (DOS) have been explored as more effective perioperative regimens for these tumors. Methods Eligible patients had large type 3 or type 4 gastric cancer without distant metastases, except for positive peritoneal cytology (CY). Patients received three cycles of neoadjuvant DOS (docetaxel 40 mg/m2, oxaliplatin 100 mg/m2, and oral S-1 at 80 mg/m2/day for 14 days), followed by gastrectomy with ≥ D2 lymphadenectomy and one year of adjuvant docetaxel plus S-1. The primary endpoint was the 3 year progression-free survival (PFS) rate, with an expected value of 60% and a threshold of 45%. A one-sample log-rank test was performed with an α level of 0.10. Results Of the 48 patients enrolled, 27 had type 4 tumors (56.2%), and 10 (20.8%) had CY1. Overall, 91.7% of patients completed neoadjuvant DOS. R0 resection rate was achieved in 89.6% of patients, a pathological response grade ≥ 1b in 66.7%, and negative CY conversion in 80.0%. The 3-year PFS rate was 37.5% (95% confidence interval [CI], 24.1–50.6%; 80% CI 28.6–46.4%; p = 0.960), and the 3-year overall survival rate was 52.1% (95% CI 37.2–65.0%). Conclusions Although neoadjuvant DOS therapy demonstrated favorable pathological responses, the 3-year PFS did not exceed the predefined threshold, and a survival benefit was not demonstrated.
- Open Access
- 11 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70200
Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome
Introduction: Pancreaticoduodenal and gastroduodenal artery aneurysms (PDAA and GDAA) are rare but life‐threatening vascular lesions. Many are associated with median arcuate ligament syndrome (MALS), a condition associated with increased retrograde collateral flow due to celiac artery compression. Although endovascular treatment is the first‐line approach for PDAA and GDAA, the role and timing of median arcuate ligament (MAL) release remain unclear. Methods: This consensus statement was developed through the Anatomy on the Border Expert Consensus Meeting, organized by the Japanese Society for Endoscopic Surgery. Among multiple clinical questions (CQs) addressed by the working group, this statement focuses on CQ3: the appropriate timing of MAL release in patients with PDAA or GDAA associated with MALS. Consensus statements were developed based on a literature review, a nationwide survey, expert panel discussions, and a modified Delphi voting process. Results: Although evidence remains limited, MAL release may improve antegrade visceral perfusion, prevent ischemic complications, reduce retrograde hemodynamic stress and recurrence risk, and facilitate vascular access for future interventions. Based on current evidence and expert input, the committee developed and approved three consensus statements: MAL release could be considered before endovascular treatment in clinically stable cases; Endovascular treatment should be performed first in ruptured cases, with careful attention to end‐organ ischemia; Elective MAL release is suggested after aneurysm treatment to reduce the risk of recurrence. Conclusion: These consensus statements support individualized surgical decision‐making for patients with PDAA or GDAA associated with MALS, where evidence is limited and clinical practice varies.
- 11 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70200
Open AccessConsensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome
Introduction: Pancreaticoduodenal and gastroduodenal artery aneurysms (PDAA and GDAA) are rare but life‐threatening vascular lesions. Many are associated with median arcuate ligament syndrome (MALS), a condition associated with increased retrograde collateral flow due to celiac artery compression. Although endovascular treatment is the first‐line approach for PDAA and GDAA, the role and timing of median arcuate ligament (MAL) release remain unclear. Methods: This consensus statement was developed through the Anatomy on the Border Expert Consensus Meeting, organized by the Japanese Society for Endoscopic Surgery. Among multiple clinical questions (CQs) addressed by the working group, this statement focuses on CQ3: the appropriate timing of MAL release in patients with PDAA or GDAA associated with MALS. Consensus statements were developed based on a literature review, a nationwide survey, expert panel discussions, and a modified Delphi voting process. Results: Although evidence remains limited, MAL release may improve antegrade visceral perfusion, prevent ischemic complications, reduce retrograde hemodynamic stress and recurrence risk, and facilitate vascular access for future interventions. Based on current evidence and expert input, the committee developed and approved three consensus statements: MAL release could be considered before endovascular treatment in clinically stable cases; Endovascular treatment should be performed first in ruptured cases, with careful attention to end‐organ ischemia; Elective MAL release is suggested after aneurysm treatment to reduce the risk of recurrence. Conclusion: These consensus statements support individualized surgical decision‐making for patients with PDAA or GDAA associated with MALS, where evidence is limited and clinical practice varies.
- Open Access
- 5 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70206
Management of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements
Background and Aims: Division of the pancreatic arterial arcade during pancreaticoduodenectomy (PD) can precipitate visceral ischemia in patients with celiac artery stenosis (CAS). This study investigated optimal management of CAS for patients undergoing PD—particularly stenosis caused by median arcuate ligament (MAL) compression—through a systematic review and a nationwide survey. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we searched for studies indexed with the Medical Subject Headings terms celiac artery stenosis , median arcuate ligament syndrome , and pancreaticoduodenectomy . In parallel, a questionnaire on CAS management during PD was distributed to 67 major hepatobiliary and pancreatic surgery centers in Japan. Results: Fifty‐five studies met the inclusion criteria, comprising eight retrospective studies, and 47 case reports/series. Meta‐analysis showed a prevalence of CAS in 6.1% of patients undergoing PD or total pancreatectomy, while preemptive MAL release was performed in only 2.2%. The risk of postoperative ischemic complications increased substantially when stenosis exceeded 80%. Among 108 patients with detailed postoperative data, those diagnosed with CAS preoperatively experienced significantly fewer ischemic events (5/85, 5.8%) compared with those diagnosed intraoperatively or postoperatively (8/22, 36%, p = 0.0006). Survey results indicated that the gastroduodenal artery (GDA) clamping test, supplemented with intraoperative Doppler ultrasonography in addition to visual inspection, was a common method to guide immediate MAL release. Repeated flow measurements after MAL release with GDA clamping were often required to confirm adequate visceral perfusion. Conclusions: Accurate preoperative identification of CAS and deliberate surgical planning are essential when PD is anticipated. Intraoperative hemodynamic reassessment remains critical, with consideration of arterial reconstruction when MAL release alone fails to restore sufficient splanchnic perfusion.
- 5 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70206
Open AccessManagement of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements
Background and Aims: Division of the pancreatic arterial arcade during pancreaticoduodenectomy (PD) can precipitate visceral ischemia in patients with celiac artery stenosis (CAS). This study investigated optimal management of CAS for patients undergoing PD—particularly stenosis caused by median arcuate ligament (MAL) compression—through a systematic review and a nationwide survey. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we searched for studies indexed with the Medical Subject Headings terms celiac artery stenosis , median arcuate ligament syndrome , and pancreaticoduodenectomy . In parallel, a questionnaire on CAS management during PD was distributed to 67 major hepatobiliary and pancreatic surgery centers in Japan. Results: Fifty‐five studies met the inclusion criteria, comprising eight retrospective studies, and 47 case reports/series. Meta‐analysis showed a prevalence of CAS in 6.1% of patients undergoing PD or total pancreatectomy, while preemptive MAL release was performed in only 2.2%. The risk of postoperative ischemic complications increased substantially when stenosis exceeded 80%. Among 108 patients with detailed postoperative data, those diagnosed with CAS preoperatively experienced significantly fewer ischemic events (5/85, 5.8%) compared with those diagnosed intraoperatively or postoperatively (8/22, 36%, p = 0.0006). Survey results indicated that the gastroduodenal artery (GDA) clamping test, supplemented with intraoperative Doppler ultrasonography in addition to visual inspection, was a common method to guide immediate MAL release. Repeated flow measurements after MAL release with GDA clamping were often required to confirm adequate visceral perfusion. Conclusions: Accurate preoperative identification of CAS and deliberate surgical planning are essential when PD is anticipated. Intraoperative hemodynamic reassessment remains critical, with consideration of arterial reconstruction when MAL release alone fails to restore sufficient splanchnic perfusion.
- Open Access
- 19 December 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70208
Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting
Background: With the increasing use of minimally invasive surgery, understanding of the precise anatomy involved in median arcuate ligament syndrome (MALS) has advanced. However, surgical strategies and treatment principles for MALS remain unclear. Methods: At the 37th Annual Meeting of the Japan Society for Endoscopic Surgery, an expert consensus conference titled “AOB Consensus Meeting” was held. Eleven experts in upper gastrointestinal, hepatobiliary‐pancreatic, and vascular surgery discussed five clinical questions (CQs) regarding MALS. Systematic literature reviews were conducted, and draft consensus statements were developed. Evidence levels were assessed based on the MINDS guideline, and final consensus statements were established through a second‐round Delphi voting process. Results: Thirteen consensus statements were formulated across the five CQs, all achieving over 75% agreement among the experts. Conclusion: This consensus provides evidence‐ and experience‐based recommendations for the diagnosis and surgical treatment of MALS. These consensus statements are expected to serve as a practical guide for specialists and surgeons, promoting the safe execution and appropriate global dissemination of MALS treatment.
- 19 December 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70208
Open AccessConsensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting
Background: With the increasing use of minimally invasive surgery, understanding of the precise anatomy involved in median arcuate ligament syndrome (MALS) has advanced. However, surgical strategies and treatment principles for MALS remain unclear. Methods: At the 37th Annual Meeting of the Japan Society for Endoscopic Surgery, an expert consensus conference titled “AOB Consensus Meeting” was held. Eleven experts in upper gastrointestinal, hepatobiliary‐pancreatic, and vascular surgery discussed five clinical questions (CQs) regarding MALS. Systematic literature reviews were conducted, and draft consensus statements were developed. Evidence levels were assessed based on the MINDS guideline, and final consensus statements were established through a second‐round Delphi voting process. Results: Thirteen consensus statements were formulated across the five CQs, all achieving over 75% agreement among the experts. Conclusion: This consensus provides evidence‐ and experience‐based recommendations for the diagnosis and surgical treatment of MALS. These consensus statements are expected to serve as a practical guide for specialists and surgeons, promoting the safe execution and appropriate global dissemination of MALS treatment.
- 17 October 2025
- Published by Springer Nature in Surgery Today
- Vol. 56 (4) , 560-566
Laparoscopic surgery for median arcuate ligament syndrome: How to do it
Median arcuate ligament syndrome (MALS) is a rare condition caused by the compression of the celiac artery and plexus, often resulting in postprandial abdominal pain. Owing to limited awareness, it is frequently misdiagnosed or inadequately treated. We herein describe our surgical approach for the management of MALS. Patients presenting with unexplained abdominal symptoms or visceral aneurysms underwent Doppler ultrasonography and three-dimensional computed tomography angiography during both inspiration and expiration to diagnose MALS. Laparoscopic surgery was performed with a camera port placed 5–7 cm cranial to the umbilicus. After incising the diaphragmatic crura and dividing the median arcuate ligament, we dissected the celiac plexus and incised the vascular sheath to completely expose the celiac artery root. Among the most recent 34 patients, all symptomatic patients experienced symptom improvement. This approach appears to be a safe and effective treatment for MALS that provides significant symptom relief.
- 17 October 2025
- Published by Springer Nature in Surgery Today
- Vol. 56 (4) , 560-566
Laparoscopic surgery for median arcuate ligament syndrome: How to do it
Median arcuate ligament syndrome (MALS) is a rare condition caused by the compression of the celiac artery and plexus, often resulting in postprandial abdominal pain. Owing to limited awareness, it is frequently misdiagnosed or inadequately treated. We herein describe our surgical approach for the management of MALS. Patients presenting with unexplained abdominal symptoms or visceral aneurysms underwent Doppler ultrasonography and three-dimensional computed tomography angiography during both inspiration and expiration to diagnose MALS. Laparoscopic surgery was performed with a camera port placed 5–7 cm cranial to the umbilicus. After incising the diaphragmatic crura and dividing the median arcuate ligament, we dissected the celiac plexus and incised the vascular sheath to completely expose the celiac artery root. Among the most recent 34 patients, all symptomatic patients experienced symptom improvement. This approach appears to be a safe and effective treatment for MALS that provides significant symptom relief.
- Open Access
- 25 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-8
Risk factors for postoperative pneumonia in older adults aged ≥ 80 years with gastric cancer
In Japan, the proportion of elderly gastric cancer patients is increasing. Although surgery in patients aged ≥ 80 years is relatively safe, postoperative pneumonia often occurs, reducing quality of life and being fatal. We retrospectively investigated the risk factors for pneumonia after gastrectomy in elderly patients at our hospital. Between 2010 and 2019, 113 patients aged ≥ 80 years underwent gastrectomy for gastric cancer at our hospital. Of these, 88 patients were retrospectively investigated, excluding 25 patients who did not receive sufficient postoperative follow-up. The diagnosis of pneumonia was based on chest CT findings. Univariate and multivariate analyzes for risk factors of pneumonia were performed using the Cox proportional hazards model. The patients were aged 80–93 years (median 83 years) and consisted of 63 males and 25 females. The surgical procedures included distal gastrectomy in 54, total gastrectomy in 25, proximal gastrectomy in two, and local resection in seven. Postoperative pneumonia was observed in 38 patients. Seventeen of them died from pneumonia. The time to onset of pneumonia was 0.2-144.6 months (median 12.0 months), and the median observation period for patients without pneumonia was 38.8 months. Multivariate analysis revealed that age, Geriatric Nutritional Risk Index, respiratory history, and extent of gastrectomy (total vs. distal: hazard ratio 3.91, 95% confidence interval 1.69–9.02) were independent pneumonia factors. In patients aged ≥ 80 years, age, low nutritional status, respiratory history, and total gastrectomy were risk factors for postoperative pneumonia.
- 25 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-8
Open AccessRisk factors for postoperative pneumonia in older adults aged ≥ 80 years with gastric cancer
In Japan, the proportion of elderly gastric cancer patients is increasing. Although surgery in patients aged ≥ 80 years is relatively safe, postoperative pneumonia often occurs, reducing quality of life and being fatal. We retrospectively investigated the risk factors for pneumonia after gastrectomy in elderly patients at our hospital. Between 2010 and 2019, 113 patients aged ≥ 80 years underwent gastrectomy for gastric cancer at our hospital. Of these, 88 patients were retrospectively investigated, excluding 25 patients who did not receive sufficient postoperative follow-up. The diagnosis of pneumonia was based on chest CT findings. Univariate and multivariate analyzes for risk factors of pneumonia were performed using the Cox proportional hazards model. The patients were aged 80–93 years (median 83 years) and consisted of 63 males and 25 females. The surgical procedures included distal gastrectomy in 54, total gastrectomy in 25, proximal gastrectomy in two, and local resection in seven. Postoperative pneumonia was observed in 38 patients. Seventeen of them died from pneumonia. The time to onset of pneumonia was 0.2-144.6 months (median 12.0 months), and the median observation period for patients without pneumonia was 38.8 months. Multivariate analysis revealed that age, Geriatric Nutritional Risk Index, respiratory history, and extent of gastrectomy (total vs. distal: hazard ratio 3.91, 95% confidence interval 1.69–9.02) were independent pneumonia factors. In patients aged ≥ 80 years, age, low nutritional status, respiratory history, and total gastrectomy were risk factors for postoperative pneumonia.
- Open Access
- 18 June 2024
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1-8
Prognostic factors for gastric cancer patients aged ≥ 85 years
Background: As gastric cancer patients aged ≥ 85 years have a short life expectancy and often die from other diseases such as pneumonia, indications for surgery are controversial. In this study, we retrospectively analyzed the prognostic factors of elderly patients with gastric cancer who are candidates for curative gastrectomy. Methods: Among 114 patients aged ≥ 85 years with gastric cancer at our hospital between 2010 and 2019, prognostic factors were examined using the Cox proportional hazards model in 76 patients excluding those with cStage IVB or endoscopic submucosal dissection. We also analyzed the factors of pneumonia death. Results: cStage was I/IIA/IIB/III/IVA in 37/6/14/14/5 patients, respectively. Treatment included distal gastrectomy in 28 patients, total gastrectomy in 6, local resection in 9, others in 3, and no surgery in 30. In univariate analyses of overall survival, Eastern Cooperative Oncology Group Performance Status, physiological score of Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM), Onodera’s prognostic nutritional index, cStage, and treatment were prognostic factors. In a multivariate analysis, POSSUM physiological score, cStage, treatment method {no surgery vs. distal gastrectomy: hazard ratio (HR) 5.78, 95% confidence interval (CI) 2.33–14.3}, (total gastrectomy vs. distal gastrectomy: HR 4.26, 95% CI 1.22–14.9) were independent prognostic factors. In univariate analyses of pneumonia-specific survival, treatment (total gastrectomy vs. distal gastrectomy: HR 6.98, 95% CI 1.18–41.3) was the only prognostic factor. Conclusions: The prognosis of distal gastrectomy was better than that of non-surgery even in patients aged ≥ 85 years. However, total gastrectomy was considered to be avoidable due to the high rate of postoperative pneumonia death.
- 18 June 2024
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1-8
Open AccessPrognostic factors for gastric cancer patients aged ≥ 85 years
Background: As gastric cancer patients aged ≥ 85 years have a short life expectancy and often die from other diseases such as pneumonia, indications for surgery are controversial. In this study, we retrospectively analyzed the prognostic factors of elderly patients with gastric cancer who are candidates for curative gastrectomy. Methods: Among 114 patients aged ≥ 85 years with gastric cancer at our hospital between 2010 and 2019, prognostic factors were examined using the Cox proportional hazards model in 76 patients excluding those with cStage IVB or endoscopic submucosal dissection. We also analyzed the factors of pneumonia death. Results: cStage was I/IIA/IIB/III/IVA in 37/6/14/14/5 patients, respectively. Treatment included distal gastrectomy in 28 patients, total gastrectomy in 6, local resection in 9, others in 3, and no surgery in 30. In univariate analyses of overall survival, Eastern Cooperative Oncology Group Performance Status, physiological score of Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM), Onodera’s prognostic nutritional index, cStage, and treatment were prognostic factors. In a multivariate analysis, POSSUM physiological score, cStage, treatment method {no surgery vs. distal gastrectomy: hazard ratio (HR) 5.78, 95% confidence interval (CI) 2.33–14.3}, (total gastrectomy vs. distal gastrectomy: HR 4.26, 95% CI 1.22–14.9) were independent prognostic factors. In univariate analyses of pneumonia-specific survival, treatment (total gastrectomy vs. distal gastrectomy: HR 6.98, 95% CI 1.18–41.3) was the only prognostic factor. Conclusions: The prognosis of distal gastrectomy was better than that of non-surgery even in patients aged ≥ 85 years. However, total gastrectomy was considered to be avoidable due to the high rate of postoperative pneumonia death.
- 26 July 2023
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 43 (8) , 3685-3691
Proximal Resection Line Determination Using Intraoperative Radiography in Laparoscopic Distal Gastrectomy for Gastric Cancer
Background/Aim: Laparoscopic distal gastrectomy for gastric cancer has become a common procedure in many institutions. As manual palpation is impossible, various methods have been developed to identify the location of the tumor and determine the proximal resection line. Intraoperative endoscopy requires manpower and is time-consuming. The authors take an intraoperative X-ray. Here, we demonstrate our methods and outcomes. Patients and Methods: We preoperatively applied metal clips just proximal to the tumor through esophagogastroduodenoscopy. During surgery, we applied metal vessel clips to the greater and lesser curvatures of the planned resection line of the stomach and took an intraoperative X-ray to examine the distance between the planned resection line and the tumor. If the distance was appropriate, the stomach was resected on the planned line, and if the distance was judged to be insufficient, the stomach was resected on the more proximal line, as appropriate. An intraoperative frozen section of the proximal resection margin was examined, as appropriate. Results: We performed this method for 71 patients. Tumors were successfully resected together with preoperative endoscopic clips in all patients. In five patients, intraoperative frozen section of the proximal resection margins was positive; however, additional resection confirmed negative margins. One patient underwent total gastrectomy, and the remaining 70 patients underwent distal gastrectomy. Conclusion: An intraoperative X-ray seems to be a simple and useful method for identifying the location of the tumor and determining the proximal resection line.
- 26 July 2023
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 43 (8) , 3685-3691
Proximal Resection Line Determination Using Intraoperative Radiography in Laparoscopic Distal Gastrectomy for Gastric Cancer
Background/Aim: Laparoscopic distal gastrectomy for gastric cancer has become a common procedure in many institutions. As manual palpation is impossible, various methods have been developed to identify the location of the tumor and determine the proximal resection line. Intraoperative endoscopy requires manpower and is time-consuming. The authors take an intraoperative X-ray. Here, we demonstrate our methods and outcomes. Patients and Methods: We preoperatively applied metal clips just proximal to the tumor through esophagogastroduodenoscopy. During surgery, we applied metal vessel clips to the greater and lesser curvatures of the planned resection line of the stomach and took an intraoperative X-ray to examine the distance between the planned resection line and the tumor. If the distance was appropriate, the stomach was resected on the planned line, and if the distance was judged to be insufficient, the stomach was resected on the more proximal line, as appropriate. An intraoperative frozen section of the proximal resection margin was examined, as appropriate. Results: We performed this method for 71 patients. Tumors were successfully resected together with preoperative endoscopic clips in all patients. In five patients, intraoperative frozen section of the proximal resection margins was positive; however, additional resection confirmed negative margins. One patient underwent total gastrectomy, and the remaining 70 patients underwent distal gastrectomy. Conclusion: An intraoperative X-ray seems to be a simple and useful method for identifying the location of the tumor and determining the proximal resection line.